PT - JOURNAL ARTICLE AU - Schindera, Christina AU - Kuehni, Claudia E. AU - Pavlovic, Mladen AU - Haegler-Laube, Eva AU - Waespe, Nicolas AU - Roessler, Jochen AU - Suter, Thomas M. AU - von der Weid, Nicolas X. AU - on behalf of the Swiss Pediatric Oncology Group (SPOG) TI - Prospective Single Center Cohort Study for Early Diagnosis of Cardiac Dysfunction in Swiss Childhood Cancer Survivors: A Study Protocol AID - 10.1101/2020.01.10.20017152 DP - 2020 Jan 01 TA - medRxiv PG - 2020.01.10.20017152 4099 - http://medrxiv.org/content/early/2020/01/16/2020.01.10.20017152.short 4100 - http://medrxiv.org/content/early/2020/01/16/2020.01.10.20017152.full AB - Introduction Cardiovascular disease is the leading nonmalignant cause of late deaths in childhood cancer survivors. Cardiovascular disease and cardiac dysfunction can remain asymptomatic for many years, but eventually lead to progressive disease with high morbidity and mortality. Early detection and intervention are therefore crucial to improve outcome. In our study, we aim to 1) assess the prevalence of early cardiac dysfunction in adult childhood cancer survivors using conventional and speckle tracking echocardiography, 2) determine the association between cardiac dysfunction and treatment-related risk factors (anthracyclines, alkylating agents, steroids, cardiac radiation) and modifiable cardiovascular risk factors (abdominal obesity, hypertension), 3) investigate the development of cardiac dysfunction longitudinally in a defined cohort, 4) study the association between cardiac dysfunction and other health outcomes like pulmonary, endocrine, and renal diseases, quality of life, fatigue, strength and endurance, and physical activity, and 5) gain experience conducting a clinical study of childhood cancer survivors that will be extended to a national, multicenter study of cardiac complications.Methods We will invite ≥5 year childhood cancer survivors who were treated at the University Children’s Hospital Bern, Switzerland with any chemotherapy and/or cardiac radiation since 1976 and who are ≥18 years of age at time of study for a cardiac assessment at the University Hospital Bern. This includes overall 544 childhood cancer survivors, of whom about half were treated with anthracyclines and/or cardiac radiation and half with any other chemotherapy. The standardized cardiac assessment includes a medical history focusing on signs of cardiovascular disease and its risk factors, a physical examination, anthropometry, vital parameters, the 1-minute sit-to-stand test, and an echocardiography including speckle tracking.Results We will invite 544 eligible childhood cancer survivors for a cardiac assessment with a median age at study of 32.5 years and a median times since diagnosis of 25.0 years. Three hundred survivors (55%) are at high risk and 244 survivors (45%) are at standard risk for cardiac dysfunction.Discussion The results of this study will show the prevalence of early cardiac dysfunction in Swiss childhood cancer survivors, inform whether speckle tracking echocardiography is more sensitive to cardiac dysfunction than conventional echocardiography, and give a detailed picture of risk factors for cardiac dysfunction. The results will help improve primary treatment and follow-up care of children suffering from cancer.Trial registration Prospectively registered in ClinicalTrials.gov, Identifier: NCT03790943, registration date 25.06.2018.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialClinicalTrials.gov, Identifier: NCT03790943Funding StatementThis study is supported by the Swiss Cancer League (KLS-3886-02-2016) which funds the salary of a PhD-student (CS) and a study nurse. The Stiftung für krebskranke Kinder, Regio basiliensis (AND-4641-01-2018) gave a travel grant to CS for a research visit to St. Jude Children’s Research Hospital, Memphis, TN, USA. The work of the Childhood Cancer Registry is supported by the Swiss Pediatric Oncology Group (www.spog.ch), Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren (www.gdk-cds.ch), Swiss Cancer Research (www.krebsforschung.ch), Kinderkrebshilfe Schweiz (www.kinderkrebshilfe.ch), the Federal Office of Public Health (FOPH), and the National Institute of Cancer Epidemiology and Registration (www.nicer.org).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesResearchers interested in collaborative work can contact the corresponding author (Claudia E. Kuehni; claudia.kuehni@ispm.unibe.ch) to discuss planned projects or analyses of existing data. The final decision will be made upon presentation of the project to the study’s principal investigators.2D2-dimensional3D3-dimensionalBMIBody mass indexCCSChildhood cancer survivorsCISChecklist Individual StrengthCSCircumferential strainEPeak mitral flow velocityE/AEarly to late left ventricle filling velocitye’Annular early diastolic velocityE/e’Peak mitral flow velocityICCC3International Classification of Childhood Cancer third editionIQRInterquartile rangeLSLongitudinal strainLVEFLeft ventricular ejection fractionNNumbersPARSeven-Day Physical Activity Recall questionnaireRARight atriumRSRadial strainRVRight ventricleSF-36Short Form 36 Health SurveySTS1-minute sit-to-stand test